Business Description
ZYUS Life Sciences Corp
NAICS : 325410
SIC : 3741
ISIN : CA9899601095
Description
ZYUS Life Sciences Corp is primarily engaged in the world-wide development and commercialization of cannabinoid-based therapeutics and product candidates. It is a licensed producer and distributor of medical cannabis for both medical and adult recreational access in Canada. The company has one reportable segment: Bio-pharmaceutical Products (including medical cannabis derivatives). Geographically, it operates in Canada; United States; Australia; and European Union.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.02 | |||||
Equity-to-Asset | -1.2 | |||||
Debt-to-Equity | -1.17 | |||||
Debt-to-EBITDA | -0.49 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -34.87 | |||||
Beneish M-Score | -3.53 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 32.6 | |||||
3-Year EBITDA Growth Rate | -22.3 | |||||
3-Year EPS without NRI Growth Rate | 16.6 | |||||
3-Year FCF Growth Rate | 23.9 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 51.52 | |||||
9-Day RSI | 45.99 | |||||
14-Day RSI | 44.46 | |||||
3-1 Month Momentum % | -21.43 | |||||
6-1 Month Momentum % | -18.85 | |||||
12-1 Month Momentum % | -30.28 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.1 | |||||
Quick Ratio | 0.07 | |||||
Cash Ratio | 0.02 | |||||
Days Inventory | 751.5 | |||||
Days Sales Outstanding | 235.8 | |||||
Days Payable | 4050.24 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2.1 | |||||
Shareholder Yield % | -9.44 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 13.12 | |||||
Operating Margin % | -2931.4 | |||||
Net Margin % | -7256.77 | |||||
EBITDA Margin % | -6695.91 | |||||
FCF Margin % | -1886.2 | |||||
OCF Margin % | -1886.2 | |||||
ROA % | -201.4 | |||||
ROIC % | -62.24 | |||||
ROC (Joel Greenblatt) % | -324 | |||||
ROCE % | -1641.78 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 70.71 | |||||
EV-to-EBIT | -1.6 | |||||
EV-to-EBITDA | -1.75 | |||||
EV-to-Revenue | 117.04 | |||||
EV-to-Forward-Revenue | 124.21 | |||||
EV-to-FCF | -5.07 | |||||
Earnings Yield (Greenblatt) % | -62.5 | |||||
FCF Yield % | -27.07 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ZYUS Life Sciences Corp Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | 0.413 | ||
| EPS (TTM) (C$) | -0.27 | ||
| Beta | 0.4112 | ||
| 3-Year Sharpe Ratio | -1.25 | ||
| 3-Year Sortino Ratio | -1.38 | ||
| Volatility % | 20.6 | ||
| 14-Day RSI | 44.46 | ||
| 14-Day ATR (C$) | 0.00072 | ||
| 20-Day SMA (C$) | 0.495 | ||
| 12-1 Month Momentum % | -30.28 | ||
| 52-Week Range (C$) | 0.395 - 0.77 | ||
| Shares Outstanding (Mil) | 80.07 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ZYUS Life Sciences Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ZYUS Life Sciences Corp Stock Events
| Event | Date | Price (C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
ZYUS Life Sciences Corp Frequently Asked Questions
What is ZYUS Life Sciences Corp(TSXV:ZYUS)'s stock price today?
The current price of TSXV:ZYUS is C$0.50. The 52 week high of TSXV:ZYUS is C$0.77 and 52 week low is C$0.40.
When is next earnings date of ZYUS Life Sciences Corp(TSXV:ZYUS)?
The next earnings date of ZYUS Life Sciences Corp(TSXV:ZYUS) is .
Does ZYUS Life Sciences Corp(TSXV:ZYUS) pay dividends? If so, how much?
ZYUS Life Sciences Corp(TSXV:ZYUS) does not pay dividend.
Press Release
Articles on ZYUS Life Sciences Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers